APPLICATION
ANDA211287
TYPE
ANDA
ORIGINAL APPROVAL
2023-06-20
LATEST ACTION
2023-06-20
ROUTE
ORAL, RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
TIOTROPIUM BROMIDEPrescription
TIOTROPIUM BROMIDE EQ 0.018MG BASE/INH · POWDER · INHALATION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.